Company / Capital Returned to Shareholders per Share
United Therapeutics Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$22.31
FY2025
5-year range
$0.00 / $22.31
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#2 of 51
Health Care
What the data says
Among 51 Health Care companies, United Therapeutics is in the top 4% for capital returned to shareholders per share. Improved from $0.00 to $22.31 over the past 2 years.
Based on SEC 10-K filings.
22.31 in FY2025. Ranks 2nd among 51 companies in Health Care.
Improved from $0.00 to $22.31 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 51This company $22.31 Sector average $2.74
▼
+715.5% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 4.9% year-over-year.
- Ranks #2 out of 51 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.31 | +4.9% |
| FY2024 | $21.26 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $9.18 | -16.0% |
| FY2016 | $10.93 | +30.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026